Cover Image

Lichen Planus Pemphigoides as an Adverse Reaction to Medication Use: A Retrospective Analysis of Commonly Implicated Medication Triggers Using the FDA Adverse Events Reporting Database

Fuente: Wiley Open Access

Saved in:

Bibliographic Details
Main Authors:	Gaurav N. Pathak, Priya Agarwal, Babar K. Rao
Format:	Artículo Open Access
Published:	Wiley 2025
Subjects:	Experimental Dermatology
Online Access:	Acceder al recurso
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Association of Comorbid Trauma and Stressor‐Related Disorders in Pemphigus and Pemphigoid: A Case‐Control Study
by: Isabella J. Tan, et al.
Published: (2026)

Erythroderma Secondary to Lichen Planus Pemphigoides in a Pediatric Patient: A Challenging Diagnosis
by: Apoorva Sharma, et al.
Published: (2026)

Low‐Dose Oral Minoxidil and Associated Adverse Events: Analyses of the FDA Adverse Event Reporting System ( FAERS ) With a Focus on Pericardial Effusions
by: Aditya K. Gupta, et al.
Published: (2024)

Drug Survival in the Treatment of Mucosal Lichen Planus: A Retrospective Multicenter Study
by: Neda Cramer, et al.
Published: (2025)

Post‐Marketing Safety of Bimekizumab in Psoriasis Patients: Pharmacovigilance Data From FDA Adverse Event Reporting System
by: Tung S. Tran, et al.
Published: (2025)

A Retrospective Case Series Reporting the Clinical Efficacy and Adverse Events of Oclacitinib Administration for Skin Disease in 238 Cats
by: Marlyse R. Wehber, et al.
Published: (2026)

Is Safety Profile of Apremilast in Elderly Patients Same With That in Young and Middle‐Aged Patients? A Real‐World Disproportionality Analysis of the FDA Adverse Event Reporting System
by: Chenyang Yu, et al.
Published: (2025)

Vismodegib and Sonidegib Are Associated With an Elevated Reporting Odds of Squamous Cell Carcinoma; a Comparative Pharmacovigilance Study of the FDA Adverse Events Reporting System ( FAERS )
by: Patrick Jedlowski, et al.
Published: (2025)

Refractory Vulvovaginal Lichen Planus Responding to Oral Tofacitinib
by: Benetta Benny, et al.
Published: (2024)

Dermatological Adverse Events Associated With Lapatinib Treatment in Dogs With Urothelial Carcinoma: A Retrospective Study
by: Kosuke Horita, et al.
Published: (2026)

Unraveling the mirage of fairness cream commercials: A cross‐sectional analysis of commercials from South Asia
by: Shazli Razi, et al.
Published: (2024)

Treating Inverse Lichen Planus With Upadacitinib: A Case Study
by: Yang Ying, et al.
Published: (2025)

Nail Lichen Planus in 81 Patients: A Retrospective Study of Clinical Characteristics, Histopathological Features, and Long‐Term Treatment Outcomes
by: Juan He, et al.
Published: (2025)

Frontal Fibrosing Alopecia and Its Association With Genital Lichen Planus and Lichen Sclerosus: A Systematic Review
by: Samantha Bestavros, et al.
Published: (2026)

Severe Erosive Lichen Planus Causing Vaginal Stenosis in a Young Girl
by: Apoorva Sharma, et al.
Published: (2025)

Different Patterns of Lichen Planus in Three Members of One Family
by: Bahareh Abtahi-Naeini, et al.
Published: (2026)

The Use of Morphology‐Directed Targeted Immunosuppression With Dupilumab in Cutaneous Immunotherapy Related Adverse Events
by: Brittany Dulmage, et al.
Published: (2025)

Medication‐Induced Lichen Sclerosus: A Systematic Review
by: Samar Alyousef, et al.
Published: (2025)

Erosive Lichen Planus Treated With Tofacitinib: A Case Series of 23 Patients
by: Vera Y. Miao, et al.
Published: (2025)

Dermatologic Immune‐Related Adverse Events: The Key to Success
by: Ariadna Ortiz‐Brugués, et al.
Published: (2026)

Differential Cutaneous Responses to Baricitinib in Concomitant Lichen Planus and Localized Eczematous Dermatitis in an Atopic Patient
by: Shiomi Iwata, et al.
Published: (2026)

Analysis of Medical Costs of Melanoma Using a Japanese National Database
by: Meiko Goto, et al.
Published: (2026)

Use of Lebrikizumab in Treatment‐Refractory Bullous Pemphigoid: Two Reports
by: Christoph Zeyen, et al.
Published: (2026)

Unilateral Mosaic Pattern of Cutaneous Immune‐Related Adverse Event Induced by Pembrolizumab: A Case Report
by: Kazumori Takamoto, et al.
Published: (2026)

Systematic Review and Meta‐Analysis of the Efficacy and Risk of Adverse Events of Dupilumab in the Treatment of Prurigo Nodularis
by: Hicham Titou, et al.
Published: (2025)

Retrospective Analysis of Clinical and Immunoserological Features in 86 Cases of Anti‐p200 Pemphigoid
by: Li Suo, et al.
Published: (2025)

The Dapsone Conundrum: Understanding Implications of Adverse Reactions to Dapsone Including Dapsone Hypersensitivity Syndrome in Leprosy Patients Treated With Multidrug Therapy
by: Anubha Dev, et al.
Published: (2025)

Oral Lichen Planus in Patients With Metal‐Containing Dental Hardware: A 13‐Year Observational Cohort Study
by: Seneca D. Hutson, et al.
Published: (2026)

Efficacy of PicoSure Laser in Treating Lichen Planus Pigmentosus and Pigmentary Demarcation Lines in Patients With Skin of Color
by: Kiran Sethi, et al.
Published: (2026)

Dupilumab for the Treatment of Cutaneous Immune‐Related Adverse Events: A Systematic Review
by: Ioannis‐Alexios Koumprentziotis, et al.
Published: (2025)

Severe Oral Lichen Planus Masking a Primary Immunodeficiency: X‐Linked Lymphoproliferative Disease Type 1 ( XLP ‐1)
by: Magí Brufau‐Cochs, et al.
Published: (2025)

Effectiveness of Dupilumab and Omalizumab in Bullous Pemphigoid: A Nationwide Retrospective Cohort Study
by: Gianluca Avallone, et al.
Published: (2025)

Efficacy of 1064‐nm Picosecond Laser in the Treatment of Lichen Planus Pigmentosus: A Split‐Face Randomized Controlled Trial
by: Suthinee Rutnin, et al.
Published: (2026)

A‐ MACE ‐Ing: A Real‐World Analysis of Semaglutide's Impact on Major Adverse Cardiovascular Events ( MACE ) in Patients With Hidradenitis Suppurativa
by: Rahib K. Islam, et al.
Published: (2025)

Systematic Review of Rare Major Adverse Cardiovascular Events Associated With the Treatment of Acne With Isotretinoin
by: Timothy L. Cowan, et al.
Published: (2025)

Atypical Neutrophilic Dermatosis Induced by Ibrutinib: A Dose‐Dependent Cutaneous Adverse Reaction
by: Jeanne Renuy, et al.
Published: (2025)

Adverse Reactions Following Intradermal Injection of Exosome‐Based Formulations: A Case Series
by: Kui Young Park
Published: (2025)

BP230 ‐Type Bullous Pemphigoid is a Rare Subset of Bullous Pemphigoid Associated With a Favorable Prognosis: A Retrospective Analysis From a Tertiary Referral Center
by: Roberto Maglie, et al.
Published: (2025)

Randomised, Double‐Blinded, Placebo‐Controlled Challenge Test With Single Food Items in Dogs With Atopic Dermatitis and Adverse Food Reactions
by: Evi I. Sofou, et al.
Published: (2025)

Lichen Sclerosus Is Associated With Atopic Conditions: A Retrospective Population‐Level Study
by: Alexa C. Kassels, et al.
Published: (2025)